Trial: 202004122

ACNS1833 – A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727, IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG)not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)

Phase

III

Principal Investigator

Cluster, Andrew

Disease Site

Brain and Nervous System

Learn more about this study at: clinicaltrials.gov